# Fresenius Medical Care AG: financial statements, quarterly

FMS · NYSE · CIK 1333141 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/fms.md) · [Financials](/companies/fms/financials.md) · [Filings](/companies/fms/filings.md) · [Insiders](/companies/fms/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fms/financials.md?period=annual).

## Balance sheet

| Line item | Unit | Q4 FY2014 (2014-12-31) | Q4 FY2015 (2015-12-31) | Q4 FY2016 (2016-12-31) | FY2017 (2017-12-31) | Q4 FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001047469-17-000816.md) | [0.5](/filings/0001047469-17-000816.md) | [0.7](/filings/0001047469-17-000816.md) | [1.0](/filings/0001047469-21-000424.md) | [2.1](/filings/0001104659-22-025549.md) | [1.0](/filings/0001104659-23-024168.md) | [1.1](/filings/0001104659-23-024168.md) | [1.5](/filings/0001104659-23-024168.md) | [1.3](/filings/0001104659-24-025293.md) | [1.4](/filings/0001104659-25-016784.md) | [1.2](/filings/0001104659-26-019005.md) | [1.6](/filings/0001104659-26-019005.md) |
| Current assets | $bn | [6.7](/filings/0001047469-16-010364.md) | [6.8](/filings/0001047469-17-000816.md) | [7.3](/filings/0001047469-17-000816.md) | [6.4](/filings/0001047469-19-000562.md) | [7.8](/filings/0001047469-20-000960.md) | [7.2](/filings/0001047469-21-000424.md) | [7.3](/filings/0001104659-22-025549.md) | [8.0](/filings/0001104659-23-024168.md) | [8.2](/filings/0001104659-24-025293.md) | [8.7](/filings/0001104659-25-016784.md) | [7.9](/filings/0001104659-26-019005.md) | [7.9](/filings/0001104659-26-019005.md) |
| Total assets | $bn | [25.4](/filings/0001047469-16-010364.md) | [25.4](/filings/0001047469-17-000816.md) | [26.9](/filings/0001047469-17-000816.md) | [24.0](/filings/0001047469-20-000960.md) | [26.2](/filings/0001047469-21-000424.md) | [32.9](/filings/0001104659-22-025549.md) | [31.7](/filings/0001104659-23-024168.md) | [34.4](/filings/0001104659-24-025293.md) | [35.8](/filings/0001104659-25-016784.md) | [33.9](/filings/0001104659-26-019005.md) | [33.6](/filings/0001104659-26-019005.md) | [31.0](/filings/0001104659-26-019005.md) |
| Current liabilities | $bn | [3.5](/filings/0001047469-16-010364.md) | [4.1](/filings/0001047469-17-000816.md) | [5.0](/filings/0001047469-17-000816.md) | [5.3](/filings/0001047469-19-000562.md) | [6.3](/filings/0001047469-20-000960.md) | [7.1](/filings/0001047469-21-000424.md) | [6.1](/filings/0001104659-22-025549.md) | [7.3](/filings/0001104659-23-024168.md) | [6.5](/filings/0001104659-24-025293.md) | [6.1](/filings/0001104659-25-016784.md) | [5.7](/filings/0001104659-26-019005.md) | [6.2](/filings/0001104659-26-019005.md) |
| Total liabilities | $bn | [14.5](/filings/0001047469-16-010364.md) | [13.8](/filings/0001047469-17-000816.md) | [14.2](/filings/0001047469-17-000816.md) | [13.2](/filings/0001047469-19-000562.md) | [13.3](/filings/0001047469-20-000960.md) | [19.7](/filings/0001047469-21-000424.md) | [19.4](/filings/0001104659-22-025549.md) | [20.4](/filings/0001104659-23-024168.md) | [20.3](/filings/0001104659-24-025293.md) | [19.1](/filings/0001104659-25-016784.md) | [17.8](/filings/0001104659-26-019005.md) | [16.7](/filings/0001104659-26-019005.md) |
| Long-term debt | $bn | [9.0](/filings/0001047469-16-010364.md) | [7.9](/filings/0001047469-17-000816.md) | [7.2](/filings/0001047469-17-000816.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.1](/filings/0001047469-16-010364.md) | [0.1](/filings/0001047469-17-000816.md) | [0.6](/filings/0001047469-17-000816.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.1](/filings/0001047469-16-010364.md) | [0.1](/filings/0001047469-17-000816.md) | [0.6](/filings/0001047469-17-000816.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [9.4](/filings/0001047469-16-010364.md) | [9.9](/filings/0001047469-17-000816.md) | [10.8](/filings/0001047469-17-000816.md) | [9.8](/filings/0001047469-19-000562.md) | [11.8](/filings/0001047469-20-000960.md) | [12.0](/filings/0001047469-21-000424.md) | [11.2](/filings/0001104659-22-025549.md) | [12.7](/filings/0001104659-23-024168.md) | [14.0](/filings/0001104659-24-025293.md) | [13.6](/filings/0001104659-25-016784.md) | [14.6](/filings/0001104659-26-019005.md) | [13.3](/filings/0001104659-26-019005.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, ifrs-full:CashAndCashEquivalents
- Current assets: us-gaap:AssetsCurrent, ifrs-full:CurrentAssets
- Total assets: us-gaap:Assets, ifrs-full:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent, ifrs-full:CurrentLiabilities
- Total liabilities: us-gaap:Liabilities, ifrs-full:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 279,288,885 at 2025-12-31, from the cover of the [20-F filed 2026-02-24](/filings/0001104659-26-019005.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.